StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) operating KPIs

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca average global full-time equivalent employees during year (employees)

Form 20-F Note 30 — Employee Costs & Numbers (Inline XBRL)

Latest, FY2025
95,100
Period ended Dec 31, 2025
Change on a year earlier
+2.4%
92,900 in FY2024
History
7 years
Since FY2019
Sources
4
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAverage global full-time equivalent employees during year (employees)Year on yearSource
FY2025Dec 31, 202595,100+2.4%Form 20-F FY2025 Annual Report ↗
FY2024Dec 31, 202492,900+7.5%Form 20-F FY2025 Annual Report ↗
FY2023Dec 31, 202386,400+5.4%Form 20-F FY2025 Annual Report ↗
FY2022Dec 31, 202282,000+3.0%Form 20-F FY2024 Annual Report ↗
FY2021Dec 31, 202179,600+6.4%Form 20-F FY2023 Annual Report ↗
FY2020Dec 31, 202074,800+11.1%Form 20-F FY2023 Annual Report ↗
FY2019Dec 31, 201967,300–Form 20-F FY2022 Annual Report ↗

Breakdown

What makes up average global full-time equivalent employees during year (employees)

Cite this data

StockData. (2026). AstraZeneca Average global full-time equivalent employees during year (employees), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/emp_avg_total

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.